{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T09:10:28Z","timestamp":1780477828193,"version":"3.54.1"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.bioorg.2022.106145","type":"journal-article","created":{"date-parts":[[2022,9,13]],"date-time":"2022-09-13T12:02:28Z","timestamp":1663070548000},"page":"106145","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Chemical synthesis of fluorinated and iodinated 17\u03b2-HSD3 inhibitors and evaluation for imaging prostate cancer tumors and tissue biodistribution"],"prefix":"10.1016","volume":"129","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7751-3184","authenticated-orcid":false,"given":"Donald","family":"Poirier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ren\u00e9","family":"Maltais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques A.","family":"Rousseau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenny","family":"Roy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serge","family":"Phoenix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Cort\u00e9s-Ben\u00edtez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger","family":"Lecomte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2022.106145_b0005","unstructured":"World Cancer Research Fund-American Institute for Cancer Research. https:\/\/www.wcrf.org\/ dietandcancer\/ prostate-cancer-statistics\/."},{"issue":"5-6","key":"10.1016\/j.bioorg.2022.106145_b0010","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/0960-0760(95)00209-X","article-title":"Characteristics of human types 1, 2 and 3 17\u03b2-hydroxysteroid dehydrogenase activities: oxidation\/reduction and inhibition","volume":"55","author":"Luu-The","year":"1995","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.bioorg.2022.106145_b0015","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.mce.2008.10.040","article-title":"Integrated view on 17beta-hydroxysteroid dehydrogenase","volume":"301","author":"Moeller","year":"2009","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.bioorg.2022.106145_b0020","doi-asserted-by":"crossref","first-page":"15","DOI":"10.2174\/1872214809666150201214602","article-title":"Recent patents on new steroid agents targeting the steroidogenesis for endocrine cancer treatments","volume":"9","author":"Poirier","year":"2015","journal-title":"Recent Pat. Endocr. Metab. Immune Drug Discov."},{"key":"10.1016\/j.bioorg.2022.106145_b0025","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/ddr.20263","article-title":"New cancer drugs targeting biosynthesis of estrogens and androgens","volume":"69","author":"Poirier","year":"2008","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.bioorg.2022.106145_b0030","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.steroids.2007.10.009","article-title":"Proliferative effect of androst-4-ene-3,17-dione and its metabolites in the androgen-sensitive LNCaP cell line","volume":"73","author":"Laplante","year":"2008","journal-title":"Steroids"},{"issue":"9","key":"10.1016\/j.bioorg.2022.106145_b0035","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1517\/13543776.2010.505604","article-title":"17\u03b2-Hydroxysteroid dehydrogenase inhibitors: A patent review","volume":"20","author":"Poirier","year":"2010","journal-title":"Expert Opin. Ther. Patents"},{"issue":"2","key":"10.1016\/j.bioorg.2022.106145_b0040","doi-asserted-by":"crossref","first-page":"103","DOI":"10.2174\/187221407780831957","article-title":"Hydroxysteroid Dehydrogenase (17\u03b2 -HSD3, 17\u03b2-HSD5, and 3\u03b1-HSD3) Inhibitors:Extragonadal Regulation of Intracellular Sex Steroid Hormone Levels","volume":"1","author":"Michael L. Mohler","year":"2007","journal-title":"EMI"},{"key":"10.1016\/j.bioorg.2022.106145_b0045","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1677\/ERC-08-0042","article-title":"Design and validation of specific inhibitors of 17beta-hydroxysteroid dehydrogenases for therapeutic application in breast and prostate cancer, and in endometriosis","volume":"15","author":"Day","year":"2008","journal-title":"Endocr.-Relat."},{"key":"10.1016\/j.bioorg.2022.106145_b0050","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.beem.2008.01.008","article-title":"Androgen biosynthetic pathways in the human prostate","volume":"22","author":"Luu-The","year":"2008","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bioorg.2022.106145_b0055","first-page":"212","article-title":"Steroid hormone synthetic pathways in prostate cancer","volume":"2","author":"Mostaghel","year":"2013","journal-title":"Transl. Androl. Urol."},{"key":"10.1016\/j.bioorg.2022.106145_b0060","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1210\/er.2001-0031","article-title":"Endocrine and intracrine sources of androgens in women: Inhibition of breast cancer and other roles of androgens and their precursor dehydroepiandrosterone","volume":"24","author":"Labrie","year":"2003","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.bioorg.2022.106145_b0065","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1002\/pros.10139","article-title":"Differential expression of 17\u03b2-hydroxysteroid dehydrogenase isozyme genes in prostate cancer and non-cancer tissues","volume":"53","author":"Koh","year":"2002","journal-title":"The Prostate"},{"key":"10.1016\/j.bioorg.2022.106145_b0070","doi-asserted-by":"crossref","first-page":"4447","DOI":"10.1158\/0008-5472.CAN-08-0249","article-title":"Maintenance of intratumoral androgens in metastatic prostate cancer: a mechanism for castration-resistant tumor growth","volume":"68","author":"Montgomery","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/j.bioorg.2022.106145_b0075","doi-asserted-by":"crossref","unstructured":"J.A. Locke, E. Guns, A.A. Lubik, H.H. Adomat, S.C. Hendy, C.A. Wood, S.L. Ettinger, M.E. Gleave, C.C. Nelson, Androgen levels increase by intratumoral De novo steroidogenesis during progression of castration-resistant prostate cancer, Cancer Res. 68 (2008) 6407-6415.","DOI":"10.1158\/0008-5472.CAN-07-5997"},{"key":"10.1016\/j.bioorg.2022.106145_b0080","doi-asserted-by":"crossref","first-page":"5033","DOI":"10.1158\/0008-5472.CAN-06-3332","article-title":"Intraprostatic androgens and androgen-regulated gene expression persist after testosterone suppression: therapeutic implications for castration-resistant prostate cancer","volume":"67","author":"Mostaghel","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.bioorg.2022.106145_b0085","doi-asserted-by":"crossref","first-page":"3850","DOI":"10.1210\/jc.2006-0968","article-title":"Persistent intrapostatic androgen concentration after medical castration in healthy men","volume":"91","author":"Page","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bioorg.2022.106145_b0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/srep01528","article-title":"Androgen deprivation promotes intratumoral synthesis of dihydrotestosterone from androgen metabolites in prostate cancer","volume":"3","author":"Ishizaki","year":"2013","journal-title":"Scientific Reports"},{"key":"10.1016\/j.bioorg.2022.106145_b0095","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1007\/s10517-005-0387-y","article-title":"N\u00e9E\u00e9 Kushlinski, Reductase activity of 17beta-hydroxysteroid oxidoreductase in prostatic tumors of different histological structure","volume":"139","author":"Deqtyar","year":"2005","journal-title":"Bull. Exp. Biol. Med."},{"key":"10.1016\/j.bioorg.2022.106145_b0100","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.2967\/jnumed.112.116624","article-title":"99mTc-labeled small-molecule inhibitors of prostate-specific membrane antigen for molecular imaging of prostate cancer","volume":"54","author":"Hillier","year":"2013","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.bioorg.2022.106145_b0105","doi-asserted-by":"crossref","first-page":"4504","DOI":"10.1021\/jm800111u","article-title":"Synthesis and evaluation of technetium-99m- and rhenium-labeled inhibitors of the prostate-specific membrane antigen (PSMA)","volume":"51","author":"Banerjee","year":"2008","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2022.106145_b0110","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.2967\/jnumed.110.086751","article-title":"123I-MIP-1072, a small-molecule inhibitor of prostate-specific membrane antigen, is effective at monitoring tumor response to taxane therapy","volume":"52","author":"Hillier","year":"2011","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.bioorg.2022.106145_b0115","first-page":"170","article-title":"[131I]MIP-1466, a small molecule prostate-specific membrane antigen (PSMA) inhibitor for targeted radiotherapy of prostate cancer (PCa)","volume":"53","author":"Hillier","year":"2012","journal-title":"J. Nucl. Med. Meeting Abstracts"},{"key":"10.1016\/j.bioorg.2022.106145_b0120","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/s11934-016-0575-5","article-title":"Prostate cancer imaging with novel PET tracers","volume":"17","author":"Lindenberg","year":"2016","journal-title":"Curr. Urol. Rep."},{"key":"10.1016\/j.bioorg.2022.106145_b0125","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.clon.2007.02.001","article-title":"Positron emission tomography in oncology: A review","volume":"19","author":"Wood","year":"2007","journal-title":"Clin. Oncol."},{"issue":"47","key":"10.1016\/j.bioorg.2022.106145_b0130","doi-asserted-by":"crossref","first-page":"8998","DOI":"10.1002\/anie.200800222","article-title":"Synthesis of 11C, 18F, 15O, and 13N radiolabels for positron emission tomography","volume":"47","author":"Miller","year":"2008","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.bioorg.2022.106145_b0135","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1021\/cr0782426","article-title":"Molecular imaging with PET","volume":"108","author":"Ametamey","year":"2008","journal-title":"Chem. Rev."},{"key":"10.1016\/j.bioorg.2022.106145_b0140","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1021\/cr4002879","article-title":"Fluorine in pharmaceutical industry: Fluorine-containing drugs introduced to the market in the last decade (2001\u20132011)","volume":"114","author":"Wang","year":"2014","journal-title":"Chem. Rev."},{"key":"10.1016\/j.bioorg.2022.106145_b0145","doi-asserted-by":"crossref","first-page":"9226","DOI":"10.1073\/pnas.97.16.9226","article-title":"Positron emission tomography provides molecular imaging of biological processes","volume":"97","author":"Phelps","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bioorg.2022.106145_b0150","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.jsbmb.2013.04.003","article-title":"Progesterone receptor targeting with radiolabelled steroids : An approach in predicting breast cancer response to therapy","volume":"137","author":"Cunha","year":"2013","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"46","key":"10.1016\/j.bioorg.2022.106145_b0155","doi-asserted-by":"crossref","first-page":"11426","DOI":"10.1002\/anie.201204687","article-title":"18F Labeling of arenes","volume":"51","author":"Tredwell","year":"2012","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.bioorg.2022.106145_b0160","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1021\/jm010286y","article-title":"Synthesis and optimization of a new family of type 3 17\u03b2-hydroxysteroid dehydrogenase inhibitors by parallel liquid-phase chemistry","volume":"45","author":"Maltais","year":"2002","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2022.106145_b0165","doi-asserted-by":"crossref","first-page":"5257","DOI":"10.1021\/jm058179h","article-title":"Androsterone 3alpha-ether-3beta-substituted and androsterone 3beta-substituted derivatives as inhibitors of type 3 17beta-hydroxysteroid dehydrogenase: Chemical synthesis and structure-activity relationship","volume":"48","author":"Tchedam-Ngatcha","year":"2005","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2022.106145_b0170","doi-asserted-by":"crossref","first-page":"4652","DOI":"10.1016\/j.bmc.2011.06.003","article-title":"Development of 3-substituted-androsterone derivatives as potent inhibitors of 17\u03b2-hydroxysteroid dehydrogenase type 3","volume":"19","author":"Maltais","year":"2011","journal-title":"Bioorg. Med. Chem."},{"issue":"141","key":"10.1016\/j.bioorg.2022.106145_b0175","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.jsbmb.2013.12.019","article-title":"In vitro and in vivo evaluation of a 3beta-androsterone derivative as inhibitor of 17beta-hydroxysteroid dehydrogenase type 3","volume":"141","author":"Roy","year":"2014","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.bioorg.2022.106145_b0180","doi-asserted-by":"crossref","first-page":"5433","DOI":"10.1016\/j.bmc.2015.07.049","article-title":"Design, chemical synthesis and biological evaluation of 3-spiromorpholinone\/3-spirocarbamate androsterone derivatives as inhibitors of 17\u03b2-hydroxysteroid dehydrogenase type 3","volume":"23","author":"Djigou\u00e9","year":"2015","journal-title":"Bioorg. Med. Chem."},{"issue":"7","key":"10.1016\/j.bioorg.2022.106145_b0185","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1016\/j.bmc.2017.02.008","article-title":"Impact of androstane A- and D-ring inversion on 17\u03b2-hydroxysteroid dehydrogenase type 3 inhibitory activity, androgenic effect and metabolic stability","volume":"25","author":"Cort\u00e9s-Ben\u00edtez","year":"2017","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2022.106145_b0190","doi-asserted-by":"crossref","first-page":"7070","DOI":"10.1021\/acs.jmedchem.9b00624","article-title":"A- and D-ring structural modifications of an androsterone derivative inhibiting 17\u03b2-hydroxysteroid dehydrogenase type 3: Chemical synthesis and structure-activity relationships","volume":"62","author":"Cort\u00e9s-Ben\u00edtez","year":"2019","journal-title":"J. Med. Chem."},{"issue":"2","key":"10.1016\/j.bioorg.2022.106145_b0195","doi-asserted-by":"crossref","first-page":"e0171871","DOI":"10.1371\/journal.pone.0171871","article-title":"Investigation of the in vitro and in vivo efficiency of RM-532-105, a 17\u03b2-hydroxysteroid dehydrogenase type 3 inhibitor, in LAPC-4 prostate cancer cell and tumor models","volume":"12","author":"Kenmogne","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.bioorg.2022.106145_b0200","doi-asserted-by":"crossref","first-page":"243","DOI":"10.2174\/1573408016999200729110245","article-title":"Insight into the mechanism of 17\u03b2-hydroxysteroid dehydrogenase type 3 inhibition by the androsterone derivative RM-532-105","volume":"16","author":"Stephen","year":"2020","journal-title":"Curr. Enzyme Inhib."},{"key":"10.1016\/j.bioorg.2022.106145_b0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsbmb.2021.105846","article-title":"16-Picolyl-androsterone derivative exibits potent 17\u03b2-HSD3 inhibitory activity, improved metabolic stability and cytotoxic effect on various cancer cells: Synthnesis, homology modeling and docking studies","volume":"210","author":"Cort\u00e9s-Ben\u00ectez","year":"2021","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.bioorg.2022.106145_b0210","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1002\/jlcr.2580200408","article-title":"Labbelled arylfluoride from the nucleophilic displacement of activated nitro groups by fluoride-18 ion","volume":"20","author":"Attina","year":"1983","journal-title":"J. Labelled Compd. Radiopharm."},{"key":"10.1016\/j.bioorg.2022.106145_b0215","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/j.nucmedbio.2007.07.002","article-title":"Synthesis and biological evaluation in rat and cat of [18F]12ST05 as a potential 5-HT6 PET radioligand","volume":"34","author":"Tang","year":"2007","journal-title":"Nucl. Med. Biol."},{"key":"10.1016\/j.bioorg.2022.106145_b0220","doi-asserted-by":"crossref","first-page":"3455","DOI":"10.1016\/j.ejmech.2011.05.010","article-title":"Synthesis and biological evaluation of potential 5-HT7 receptor PET radiotracers","volume":"46","author":"Andries","year":"2011","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2022.106145_b0225","doi-asserted-by":"crossref","first-page":"68","DOI":"10.2967\/jnumed.106.037200","article-title":"Skeletal PET with 18F-fluoride: applying new technology to an old tracer","volume":"49","author":"Grant","year":"2008","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.bioorg.2022.106145_b0230","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2967\/jnmt.119.234336","article-title":"18F-Sodium fluoride PET: History, technical feasibility, mechanism of action, normal biodistribution, and diagnostic performance in bone metastasis detection compared with other imaging modalities","volume":"48","author":"Ahuja","year":"2020","journal-title":"J. Nucl. Med. Technol."},{"key":"10.1016\/j.bioorg.2022.106145_b0235","doi-asserted-by":"crossref","first-page":"20399","DOI":"10.18632\/oncotarget.24911","article-title":"Measuring glucocorticoid receptor expression in vivo with PET","volume":"9","author":"Truillet","year":"2018","journal-title":"Oncotarget"},{"issue":"Suppl 1","key":"10.1016\/j.bioorg.2022.106145_b0240","first-page":"61","article-title":"Pre-binding 18F-FDHT with sex hormone binding globulin permits androgen receptor-specific PET imaging in murine models of prostate cancer","volume":"58","author":"Nesti","year":"2017","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.bioorg.2022.106145_b0245","doi-asserted-by":"crossref","first-page":"534","DOI":"10.2310\/7290.2015.00026","article-title":"PET imaging of steroid hormone receptor expression","volume":"14","author":"Allott","year":"2015","journal-title":"Mol. Imaging"},{"key":"10.1016\/j.bioorg.2022.106145_b0250","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1002\/jcc.540141112","article-title":"General atomic and molecular electronic structure system","volume":"14","author":"Schmidt","year":"1993","journal-title":"J. Comp. Chem."},{"key":"10.1016\/j.bioorg.2022.106145_b0255","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1002\/jcc.23899","article-title":"New ways to boost molecular dynamics simulations","volume":"36","author":"Krieger","year":"2015","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.bioorg.2022.106145_b0260","unstructured":"BIOVIA, Dassault Systemes, Discovery Studio Visualizer v21.1.0.20298, Dassault Systemes, San Diego, 2021."},{"key":"10.1016\/j.bioorg.2022.106145_b0265","unstructured":"LabPlot Team (2022). LabPlot: A Free, open source, cross-platform Data Visualization and Analysis software accessible to everyone, (Version 2.9). https:\/\/labplot.kde.org."},{"key":"10.1016\/j.bioorg.2022.106145_b0270","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1002\/jcc.21256","article-title":"AutoDock4 and Auto-DockTools4: Automated docking with selective receptor flexibility","volume":"30","author":"Morris","year":"2009","journal-title":"J. Comput. Chem."},{"issue":"16","key":"10.1016\/j.bioorg.2022.106145_b0275","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1002\/jcc.10349","article-title":"A point-charge force field for molecular mechanics simulations of proteins based on condensed-phase quantum mechanical calculations","volume":"24","author":"Duan","year":"2003","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.bioorg.2022.106145_b0280","doi-asserted-by":"crossref","first-page":"3696","DOI":"10.1021\/acs.jctc.5b00255","article-title":"ff14SB: Improving the accuracy of protein side chain and backbone parameters from ff99SB","volume":"11","author":"Maier","year":"2015","journal-title":"J. Chem. Theory Comput."},{"key":"10.1016\/j.bioorg.2022.106145_b0285","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1002\/jcc.20035","article-title":"Development and testing of a general amber force field","volume":"25","author":"Wang","year":"2004","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.bioorg.2022.106145_b0290","doi-asserted-by":"crossref","unstructured":"A. Jakalian, D.B. Jack, C.I. Bayly, Fast, efficient generation of high\u2010quality atomic charges. AM1\u2010BCC model: II. Param-eterization and validation. J. Comput. Chem. 23 (2002) 1623-1641.","DOI":"10.1002\/jcc.10128"},{"key":"10.1016\/j.bioorg.2022.106145_b0295","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1002\/prot.21123","article-title":"Comparison of multiple Amber force fields and development of improved protein backbone parameters","volume":"65","author":"Hornak","year":"2005","journal-title":"Proteins Struct. Funct. Bioinform."},{"key":"10.1016\/j.bioorg.2022.106145_b0300","doi-asserted-by":"crossref","first-page":"8577","DOI":"10.1063\/1.470117","article-title":"A smooth particle mesh Ewald method","volume":"103","author":"Essmann","year":"1995","journal-title":"J. Chem. Phys."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004520682200551X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004520682200551X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T08:39:34Z","timestamp":1758616774000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S004520682200551X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":60,"alternative-id":["S004520682200551X"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2022.106145","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chemical synthesis of fluorinated and iodinated 17\u03b2-HSD3 inhibitors and evaluation for imaging prostate cancer tumors and tissue biodistribution","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2022.106145","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106145"}}